Morning Market Movers

rose 27.64% to $18.70 after the FDA approved a New Drug Application for Adamas Pharmaceuticals' Namzaric for the treatment of moderate to severe dementia of the Alzheimer's type.

shares climbed 12.06% to $20.06 on positive comments from Jim Cramer on 'Mad Money.'

shares rose 8.02% to $12.79 after dropping 23.56% on Tuesday.

shares jumped 6.10% to $15.70 following news that a black male was shot and killed by police in Missouri.

shares gained 4.84% to $37.54 after analysts at multiple firms initiated favorable coverage on the stock.

gained 4.49% to $12.53 after the company reported that it has submitted a new drug application for Buprenorphine HCl Buccal Film to manage pain.

shares rose 4.06% to $64.04 after gaining 6.10% on Tuesday.